MyAverix Finance
F · Healthcare
MERCK KGAA NAM.SP.ADR (MRKC)
Drug Manufacturers - Specialty & Generic
MERCK KGAA NAM.SP.ADR (MRKC) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $45.65B, P/E ratio is 17.50, net margin is 12.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MRKC
MERCK KGAA NAM.SP.ADR (MRKC) — FAQ
What is MERCK KGAA NAM.SP.ADR's market cap?
MERCK KGAA NAM.SP.ADR (MRKC) has a reported market cap of $45.65B (data as of 2026-03-30).
What is MRKC's P/E ratio?
The price-to-earnings (P/E) ratio for MERCK KGAA NAM.SP.ADR (MRKC) is 17.50 (data as of 2026-03-30).
Does MERCK KGAA NAM.SP.ADR pay a dividend?
Dividend yield is not available in the current snapshot for MERCK KGAA NAM.SP.ADR (MRKC). Check the MyAverix Finance app for the latest dividend data.
What sector is MERCK KGAA NAM.SP.ADR in?
MERCK KGAA NAM.SP.ADR (MRKC) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is MRKC listed on?
MRKC is listed on F.
What is MERCK KGAA NAM.SP.ADR's net margin?
MERCK KGAA NAM.SP.ADR (MRKC) reports a net margin of 12.4% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.